Current role
Steven Knapp
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steven Knapp
Aclaris Therapeutics, Inc. reported in an 8-K filed November 18, 2024 that Steven Knapp was appointed Executive Vice President, Head of Regulatory & Quality.
“Steven Knapp, PharmD, joins as Executive Vice President, Head of Regulatory & Quality, with over 35 years of regulatory and quality experience from senior positions at Biosion, Antares, Valeant, and BMS.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-11-18–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aclaris Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Neal Walker CEO, Chairman, Board Member
- Kevin Balthaser CFO
- Douglas Manion COO, Board Member
- Douglas Manion, M.D., FRCP (C) COO
- Hugh Davis COO, Board Member
- Andrew Schiff, M.D. Board Member
- Vincent Milano Board Member
- William Humphries Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.